OCUP: Ocuphire Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 27.44
Enterprise Value ($M) 27.62
Book Value ($M) 5.71
Book Value / Share 1.27
Price / Book 4.83
NCAV ($M) 5.53
NCAV / Share 1.23
Price / NCAV 4.99

Profitability (mra)
Return on Invested Capital (ROIC) -0.87
Return on Assets (ROA) -0.54
Return on Equity (ROE) -0.82

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 2.88

Balance Sheet (mrq) ($M)
Current Assets 8.65
Assets 8.83
Liabilities 3.12
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -11.22
Net Income -8.64
Earnings Per Share Basic And Diluted -2.18
Earnings Per Share Diluted -2.18
Earnings Per Share Basic -2.18

Cash Flow Statement (mra) ($M)
Cash From Operations -10.28
Cash from Investing 3.10
Cash from Financing 3.10

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-11-16 13G Richmond Brothers, Inc. 5.80
2020-11-16 13G Altium Capital Management LP 8.30
2020-11-12 13G Empery Asset Management, LP 8.33 -95.27
2020-08-10 13G Armistice Capital, Llc 1.00 -98.26
2019-02-14 13G/A CVI Investments, Inc. 4.90 -1.75
2019-02-14 13G/A Anson Funds Management LP 4.90 0.82
2017-01-10 13G/A Sabby Management, Llc 4.99 -24.19
2013-10-09 13D/A Ahn Chang Ho 7.24

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-12-01 16,146 50,500 31.97
2020-11-30 11,876 80,947 14.67
2020-11-27 9,348 37,244 25.10

(click for more detail)

Similar Companies
OCAT – Ocata Therapeutics, Inc. OCRX – Ocera Therapeutics, Inc.
OCUL – Ocular Therapeutix, Inc. ODT – Odonate Therapeutics, Inc.
OGI – Organigram Holdings Inc.


Financial data and stock pages provided by
Fintel.io